XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 31 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,139,000 | -37.9% | 465,049 | +3.2% | 0.02% | -35.3% |
| Q2 2021 | $1,833,000 | -6.3% | 450,414 | +3.9% | 0.03% | -17.1% |
| Q1 2021 | $1,956,000 | +27.2% | 433,710 | +38.7% | 0.04% | +17.1% |
| Q4 2020 | $1,538,000 | -25.1% | 312,590 | -9.8% | 0.04% | -50.0% |
| Q3 2020 | $2,054,000 | +127.0% | 346,428 | +1.8% | 0.07% | +112.1% |
| Q2 2020 | $905,000 | -35.5% | 340,403 | +312.6% | 0.03% | -66.7% |
| Q4 2018 | $1,403,000 | -39.2% | 82,504 | -37.1% | 0.10% | -20.8% |
| Q3 2018 | $2,306,000 | -7.1% | 131,145 | +0.3% | 0.12% | -16.1% |
| Q2 2018 | $2,481,000 | – | 130,700 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |